DREN
Fat Loss Breakthrough:
DREN WILL TRANSFORM YOUR BODY AND ALTER YOUR MIND
Researchers are calling the discovery of an exclusive new compound,
Beta-Methoxy- Phenylethylamine , a bigger and more promising breakthrough than
ephedra and are comparing DREN to Clenbuterol. Scientists have been looking at
the basic form Beta-Phenylethyamine (also called Beta-PEA) for years, but
unfortunately its short half-life prevented this compound from ever being very
effective. The first attempt to overcome the short half- life was to combine
Beta-PEA with MAO inhibitors, but this also proved to be NOT effective. However,
this new form isn’t just showing promise, its showing amazing results. And while
Beta-Methoxy-Phenylethylamine is the new General in the war against fat a few
good soldiers have been added to DREN for total annihilation of stubborn adipose
FAT!
Advanced Pharmacological Approach To Fat Annihilation!
DREN Supplement Facts:
Serving Size: 1 Capsule
Servings Per Box: 30
Amount Per Serving
Drenbuterol 409mg
Mesolimbic Beta Agonist Complex:
Caffeine, L-5 Hydroxytryptophan,
Beta Methoxyphenylethylamine, and Yohimbine HCI
DREN Other Ingredients: Yellow Opaque Gelatin Capsule, Maltodextrin, Silicon
Dioxide and Magnesium Stearate.
DREN Directions: Take 1 Capsule daily, No not exceed recommended dose
WARNING: Not intended for use by those with a medical condition. Use only as
directed. Do not exceed recommended daily intake. Not intended for use by
persons under age 18. Consult your physician prior to use if you are pregnant or
nursing, or if you are taking medication, including but not limited to, MAO
Inhibitors, antidepressants, aspirin, non-steroidal anti-inflammatory drugs or
products containing ephedrine, pseudoephedrine, synephrine, phenylephrine,
caffeine or other stimulants. Contains caffeine. Do not consume caffeine from
other sources, including but not limited to coffee, tea, soda and other dietary
supplements or medications containing caffeine. Consult your physician prior to
use if you have a medical condition, including, but not limited to, heart,
kidney, liver or thyroid disease, psychiatric or epileptic disorders, difficulty
urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent
headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery
or if you experience rapid heartbeat, dizziness, severe headache or shortness of
breath.
Do not use for more than 8 weeks.
|
